Literature DB >> 8627309

Increased neural cell adhesion molecule in the CSF of patients with mood disorder.

M Poltorak1, M A Frye, R Wright, J J Hemperly, M S George, P J Pazzaglia, S A Jerrels, R M Post, W J Freed.   

Abstract

Neural cell adhesion molecule (N-CAM) is involved in cell-cell interactions during synaptogenesis, morphogenesis, and plasticity of the nervous system. Disturbances in synaptic restructuring and neural plasticity may be related to the pathogenesis of several neuropsychiatric diseases, including mood disorders and schizophrenia. Disturbances in brain cellular function may alter concentrations of N-CAM in the CSF. Soluble human N-CAM proteins are detectable in the CSF but are minor constituents of serum. We have recently found an increase in N-CAM content in the CSF of patients with schizophrenia. Although the pathogenesis of both schizophrenia and mood disorders is unknown, ventriculomegaly, decreased temporal lobe volume, and subcortical structural abnormalities have been reported for both disorders. We have therefore measured N-CAM concentrations in the CSF of patients with mood disorder. There were significant increases in amounts of N-CAM immunoreactive proteins, primarily the 120-kDa band, in the CSF of psychiatric inpatients with bipolar mood disorder type I and recurrent unipolar major depression. There were no differences in bipolar mood disorder type II patients as compared with normals. There were no significant effects of medication treatment on N-CAM concentrations. It is possible that the 120-kDa N-CAM band present in the CSF is derived from CNS cells as a secreted soluble N-CAM isoform. Our results suggest the possibility of latent state-related disturbances in N-CAM cellular function, i.e., residue from a previous episode, or abnormal N-CAM turnover in the CNS of patients with mood disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627309     DOI: 10.1046/j.1471-4159.1996.66041532.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology.

Authors:  Claudia Ditzen; Ning Tang; Archana M Jastorff; Larysa Teplytska; Alexander Yassouridis; Giuseppina Maccarrone; Manfred Uhr; Thomas Bronisch; Christine A Miller; Florian Holsboer; Christoph W Turck
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

Review 2.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

3.  Role of a neural cell adhesion molecule found in cerebrospinal fluid as a potential biomarker for epilepsy.

Authors:  Wei Wang; Liang Wang; Jing Luo; Zhiqin Xi; Xuefeng Wang; Guojun Chen; Lan Chu
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

4.  Developmental regulation of neural cell adhesion molecule in human prefrontal cortex.

Authors:  E T Cox; L H Brennaman; K L Gable; R M Hamer; L A Glantz; A-S Lamantia; J A Lieberman; J H Gilmore; P F Maness; L F Jarskog
Journal:  Neuroscience       Date:  2009-04-22       Impact factor: 3.590

5.  Isobaric Labeling Strategy Utilizing 4-Plex N,N-Dimethyl Leucine (DiLeu) Tags Reveals Proteomic Changes Induced by Chemotherapy in Cerebrospinal Fluid of Children with B-Cell Acute Lymphoblastic Leukemia.

Authors:  Qinying Yu; Xiaofang Zhong; Bingming Chen; Yu Feng; Min Ma; Carol A Diamond; Julie S Voeller; Miriam Kim; Kenneth B DeSantes; Christian M Capitini; Neha J Patel; Margo L Hoover-Regan; Michael J Burke; Kimberly Janko; Diane M Puccetti; Chrysanthy Ikonomidou; Lingjun Li
Journal:  J Proteome Res       Date:  2020-05-27       Impact factor: 4.466

6.  Identification of gene ontologies linked to prefrontal-hippocampal functional coupling in the human brain.

Authors:  Luanna Dixson; Henrik Walter; Michael Schneider; Susanne Erk; Axel Schäfer; Leila Haddad; Oliver Grimm; Manuel Mattheisen; Markus M Nöthen; Sven Cichon; Stephanie H Witt; Marcella Rietschel; Sebastian Mohnke; Nina Seiferth; Andreas Heinz; Heike Tost; Andreas Meyer-Lindenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

7.  NCAM1 association study of bipolar disorder and schizophrenia: polymorphisms and alternatively spliced isoforms lead to similarities and differences.

Authors:  Mary E Atz; Brandi Rollins; Marquis P Vawter
Journal:  Psychiatr Genet       Date:  2007-04       Impact factor: 2.458

8.  The genetic basis of the comorbidity between cannabis use and major depression.

Authors:  Karen Hodgson; Laura Almasy; Emma E M Knowles; Jack W Kent; Joanne E Curran; Thomas D Dyer; Harald H H Göring; Rene L Olvera; Mary D Woolsey; Ravi Duggirala; Peter T Fox; John Blangero; David C Glahn
Journal:  Addiction       Date:  2016-09-26       Impact factor: 6.526

Review 9.  Intercellular protein-protein interactions at synapses.

Authors:  Xiaofei Yang; Dongmei Hou; Wei Jiang; Chen Zhang
Journal:  Protein Cell       Date:  2014-04-23       Impact factor: 14.870

Review 10.  Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

Authors:  Nilay Hepgul; Annamaria Cattaneo; Patricia A Zunszain; Carmine M Pariante
Journal:  BMC Med       Date:  2013-02-05       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.